The increase in malignant, cardiac, & neurological disorders, immediate need for effective and novel therapies, the rising human embryonic stem cell awareness and better healthcare infrastructure with government initiatives are expected to accelerate the global human embryonic stem cells market, during the forecast period.
A majority of companies are investing in the human embryonic stem cell research, globally. The high-prevalence of cardiac and malignant diseases, increasing R&D investments & research initiatives, increasing support from government & private institutions and rapid growth in medical tourism are accelerating the market growth. However, the stringent regulatory guidelines and ethical & moral concerns are restraining the market.
The global embryonic stem cells market is segmented based on application and geography. The applications segment includes regenerative medicine, stem cell biology research, tissue engineering and toxicology testing. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa and Latin America. The Asia-Pacific human embryonic stem cells market has the potential, owing to increasing initiatives of the governments & private organizations for research in human embryonic stem cells.
The major companies discussed in this report are:
Australian Stem Cell Centre
Merck Millipore Corporation
Thermo Fisher Scientific
Market analysis, with region-specific assessments and competition analysis on a global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, growing prospective opportunities, and identification of key companies that can influence the market.
Extensively researched competitive landscape section with profiles of major companies, along with their market share.
Identification and analysis of the macro and micro factors that affect the market on both, global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-range of knowledge and insights about the major players in the industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions where the industry is growing, and identify the regions that are still untapped.
1.1 Market Definition
1.2 Research Methodology
2. Executive Summary
3. Key Inferences
4. Market Overview
4.1 Current Market Scenario
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products & Services
4.2.5 Competitive Rivalry within the Industry
5. Drivers, Restraints, Opportunities & Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 High Prevalence of Cardiac and Malignant Diseases
5.1.2 Increasing R&D Investments and Research Initiatives
5.1.3 Increasing Support from Government and Private Institutions
5.1.4 Rapid Growth in Medical Tourism
5.2 Market Restraints
5.2.1 Stringent Regulatory Guidelines
5.2.2 Ethical & Moral Concerns
5.3 Market opportunities
5.4 Key Challenges
6. Market Segmentation
6.1 By Applications
6.1.1 Regenerative medicine
6.1.2 Stem Cell Biology Research
6.1.3 Tissue Engineering
6.1.4 Toxicology Testing
6.2 By Geography
6.2.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Australia & New Zealand
188.8.131.52 Rest of Asia-Pacific
6.2.4 Middle East & Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
6.2.5 South America
18.104.22.168 Rest of South America
7. Competitive Landscape
7.1 Merger and Acquisition Analysis
7.2 New Product Launches
7.3 Agreements, Collaborations and Partnerships
8. Company Profiles
8.1 Australian Stem Cell Centre
8.2 BD Biosciences
8.3 Cellartis AB
8.4 Millipore Corporation
8.5 Geron Corporation
8.6 Invitrogen Corporation
8.8 SA Biosciences Corporation
8.9 Tataa Biocenter
8.10 Thermo Scientific
8.11 Vitrolife AB
9. Future Outlook of the Market
- Australian Stem Cell Centre
- Bd Biosciences
- Cellartis Ab
- Merck Millipore Corporation
- Geron Corporation
- Invitrogen Corporation
- Viacyte Inc.
- Sabiosciences Corporation
- Tataa Biocenter
- Thermo Fisher Scientific
- Vitrolife Ab